Circulating Tumor DNA
Circulating tumor DNA (ctDNA) is genetic material released by tumors into the bloodstream and can be used to provide an insight into the genetics of the tumor. It is a promising biomarker for cancer diagnosis, treatment and prognosis, as it provides a non-invasive, real-time monitor of active cancer growth. ctDNA offers real-time changes in tumor biology that can aid in the development of tailored therapeutics, thereby leading to more effective treatment strategies. It can also be used to detect minimal residual disease (MRD) after initial treatment, for monitoring of metastatic progression, and for identification of the emergence of drug resistance in the tumor.
← Journal of Cancer Genetics And Biomarkers